BIND Therapeutics Inc Share Price Nasdaq
Equities
US05548N1072
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/01 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | - | 24/16/24 |
1st Jan change | Capi. | |
---|---|---|
+7.30% | 113B | |
+11.01% | 106B | |
+0.87% | 22.27B | |
-12.19% | 22.22B | |
-5.52% | 19.43B | |
-37.85% | 17.87B | |
-5.99% | 17.24B | |
+7.05% | 14.29B | |
+34.83% | 12.52B |